By Scientia Professor Anthony D Kelleher

Journal articles

Seddiki N; Phetsouphanh C; Swaminathan S; Xu Y; Rao S; Li J; Sutcliffe E; Denyer G; Finlayson R; Gelgor L; Cooper DA; Zaunders J; Kelleher AD, 2013, 'The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection', European Journal of Immunology, 43, pp. 510 - 520, http://dx.doi.org/10.1002/eji.201242695

, 2012, 'Track A Basic Science', Journal of the International AIDS Society, 15, http://dx.doi.org/10.7448/ias.15.5.18438

Kikuchi T; Iwabu Y; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Kelleher A; Markowitz M; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T, 2012, 'Anti-APOBEC3G activity of HIV-1 Vif protein from elite controllers is attenuated compared to those from untreated chronic progressors or those from individuals with acute infection', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310588200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

French M; Center R; Wilson K; Fleyfel I; Fernandez S; Kelleher A, 2012, 'Natural control of HIV infection is associated with an isotype switched IgG antibody response to HIV core antigens in patients with 'non-protective' HLA-B alleles', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 5 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310588200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Cooper DA, 2012, 'Acute HIV infection', , pp. 77 - 88, http://dx.doi.org/10.1016/B978-1-4557-0695-2.00006-7

Jarrin I; Pantazis N; Gill MJ; Geskus R; Perez-Hoyos S; Meyer L; Prins M; Touloumi G; Johnson A; Hamouda O; de Olalla PG; Porter K; del Amo J; CASCADE Collaboration in EuroCoord , 2012, 'Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.', Clin Infect Dis, 54, pp. 111 - 118, http://dx.doi.org/10.1093/cid/cir814

Hsu DC; Zaunders J; Plit ML; Leeman C; Ip S; Iampornsin T; Pett SL; Bailey MR; Amin J; Ubolyam S; Avihingsanon A; Ananworanich J; Ruxrungtham K; Cooper DA; Kelleher AD, 2012, 'A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays', Tuberculosis, 92, pp. 321 - 327, http://dx.doi.org/10.1016/j.tube.2012.03.008

Lodi S; Meyer L; Kelleher AD; Rosinska M; Ghosn J; Sannes M; Porter K, 2012, 'Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion', Annals of Internal Medicine, 172, pp. 1252 - 1255, http://dx.doi.org/10.1001/archinternmed.2012.2719

Sasson SC; Zaunders J; Seddiki N; Mcbride K; Koelsch KK; Merlin KM; Smith DE; Cooper DA; Kelleher AD; Bailey MR, 2012, 'Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection', PLoS One, 7, pp. e31148, http://dx.doi.org/10.1371/journal.pone.0031148

Kramski M; Schorcht A; Johnston APR; Lichtfuss G; Jegaskanda S; De rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ, 2012, 'Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity', Journal of Immunological Methods, 384, pp. 51 - 61, http://dx.doi.org/10.1016/j.jim.2012.07.006

Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; Stratov SI; Navis M; Kent SJ, 2012, 'Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection', Immunology, 138, pp. 116 - 123, http://dx.doi.org/10.1111/imm.12016

Cordery D; Martin A; Kelleher AD; Emery S; Cooper DA, 2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.', AIDS, 26, pp. 2337 - 2344, http://dx.doi.org/10.1097/QAD.0b013e32835ab213

Swaminathan S; Kelleher AD; Murray DD, 2012, 'The role of microRNAs in HIV-1 pathogenesis and therapy', AIDS, 26, pp. 1325 - 1334, http://dx.doi.org/10.1097/QAD.0b013e328352adca

Brockman M; Chopera DR; Olvera A; Brumme C; Sela J; Markle TJ; Martin EPG; Carlson JM; Le AQ; Mcgovern R; Cheung PK; Kelleher AD; Jessen H; Markowitz M; Rosenberg E; Frahm N; Sanchez J; Mallal S; John M; Harrigan PR; Heckerman D; Brander C; Walker BD; Brummea ZL, 2012, 'Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity', Journal of Virology, 86, pp. 6913 - 6923, http://dx.doi.org/10.1128/JVI.07133-11

Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR; CASCADE Collaboration , 2011, 'Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.', AIDS, 25, pp. 1395 - 1403, http://dx.doi.org/10.1097/QAD.0b013e3283489c8b

Matthews PC; Leslie AJ; Katzourakis A; Crawford H; Payne R; Prendergast A; Power K; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung'u T; Walker BD; Allen TM; Pybus OG; Goulder PJR, 2011, 'HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering', Journal of Virology, 85, pp. 4635, http://dx.doi.org/10.1128/JVI.00375-11

Hemelaar J; Gouws E; Ghys PD; Osmanov S; WHO-UNAIDS Network for HIV Isolation and Characterisation , 2011, 'Global trends in molecular epidemiology of HIV-1 during 2000-2007.', AIDS, 25, pp. 679 - 689, http://dx.doi.org/10.1097/QAD.0b013e328342ff93

Cordery DV; Humphries A; Amin J; Kelleher AD; Emery S; Cooper DA, 2011, 'The influence of HLA supertype on thymidine analogue induced body composition changes in STEAL', ANTIVIRAL THERAPY, 16, pp. A20 - A21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chung AW; Navis M; Isitman G; Centre R; Finlayson RJ; Bloch M; Gelgor L; Kelleher AD; Kent SJ; Stratov I, 2011, 'Activation of NK cells by ADCC responses during early HIV infection', Viral Immunology, 24, pp. 171 - 175, http://dx.doi.org/10.1089/vim.2010.0108

Sutcliffe E; Bunting KL; He YQ; Li J; Phetsouphanh C; Seddiki N; Zafar A; Hindmarsh EJ; Parish CR; Kelleher AD; Mcinnes RL; Taya T; Milburn PJ; Rao S, 2011, 'Chromatin-Associated Protein Kinase C-è Regulates an Inducible Gene Expression Program and MicroRNAs in Human T Lymphocytes', Molecular Cell, 41, pp. 704 - 719, http://dx.doi.org/10.1016/j.molcel.2011.02.030

Iglesias MA; Almeida JR; Fastenackels S; Van Bockel DJ; Hashimoto M; Venturi V; Gostick E; Urrutia A; Wooldridge L; Clement M; Gras S; Wilmann P; Autran B; Moris A; Rossjohn J; Davenport MP; Takiguchi M; Brander C; Douek D; Kelleher AD; Price DA; Appay V, 2011, 'Escape from highly effective public CD8+ T-cell clonotypes by HIV', Blood, 118, pp. 2138 - 2149, http://dx.doi.org/10.1182/blood-2011-01-328781

Sauce D; Larsen M; Fastenackels S; Pauchard M; Ait-mohand H; Schneider L; Guihot A; Boufassa F; Zaunders J; Iguertsira M; Bailey M; Gorochov G; Duvivier C; Carcelain G; Kelleher AD; Simon A; Meyer L; Costagliola D; Deeks SG; Lambotte O; Autran B; Hunt P; Katlama C; Appay V, 2011, 'HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis', Blood, 117, pp. 5142 - 5151, http://dx.doi.org/10.1182/blood-2011-01-331306

Van Bockel DJ; Ammaranond P; Petoumenos K; Mcmurchie M; Finlayson RJ; Middleton MG; Davenport ; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD, 2011, 'HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome', Journal of Immunology, 186, pp. 479 - 488, http://www.jimmunol.org/content/186/1/479

Munier CM; Andersen CR; Kelleher , 2011, 'HIV vaccines: Progress to date', Drugs, 71, pp. 387 - 414, http://adisonline.com/drugs/Abstract/2011/71040/HIV_Vaccines__Progress_to_Date.2.aspx

Sirivichayakul S; Thantiworasit P; Chatkulkawin P; Buranapraditkun S; Munier ML; Kelleher AD; Ruxrungtham K, 2011, 'Immunogenicity assay validation for an HIV vaccine trial: High IFNã+/IL-2+ CD8+ T cells background in healthy Thais', Vaccine, 29, pp. 6002 - 6007, http://dx.doi.org/10.1016/j.vaccine.2011.06.035

Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, 204, pp. 1532 - 1540, http://jid.oxfordjournals.org/content/204/10/1532

Murray JM; Kelleher ; Cooper DA, 2011, 'Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals', Journal of Virology, 85, pp. 10798 - 10805, http://dx.doi.org/10.1128/JVI.05095-11

Suzuki K; Ishida T; Yamagishi M; Ahlenstiel C; Swaminathan S; Marks K; Murray D; McCartney EM; Beard MR; Alexander M; Purcell DF; Cooper DA; Watanabe T; Kelleher AD, 2011, 'Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.', RNA biology, 8, pp. 1035 - 1046

Swaminathan S; Hood CL; Suzuki K; Kelleher AD, 2010, 'RNA duplexes in transcriptional regulation', Biomolecular Concepts, 1, pp. 285 - 296, http://dx.doi.org/10.1515/bmc.2010.021

French MA; Tanaskovic S; Law MG; Lim A; Fernandez S; Ward LD; Kelleher AD; Emery S, 2010, 'Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcγRIIa genotype', AIDS, 24, pp. 1983 - 1990, http://dx.doi.org/10.1097/QAD.0b013e32833c1ce0

Pett SL; Zaunders J; Bailey M; Murray JM; Macrae K; Emery S; Cooper DA; Kelleher AD, 2010, 'A novel Chemokine-Receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection', AIDS Research and Human Retroviruses, 26, pp. 653 - 661, http://dx.doi.org/10.1089/aid.2009.0278

Pett SL; Emery S; Kelleher AD; Cooper DA, 2010, 'Antiretroviral agents: Focus on Maraviroc for the Treatment of HIV-1-Infected Adults', Clinical Medicine Insights: Therapeutics, 2, http://dx.doi.org/10.4137/cmt.s5420

Brockman M; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Atfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM, 2010, 'Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection', Journal of Virology, 84, pp. 11937 - 11949

Arnott A; Jardine D; Wilson K; Gorry P; Merlin K; Grey PA; Law MG; Dax E; Kelleher AD; Smith DE; Mcphee D, 2010, 'High viral fitness during acute HIV-1 infection', PLoS One, 5, pp. e12631, http://dx.doi.org/10.1371/journal.pone.0012631

Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD, 2010, 'Impaired replication capacity of acute/early viruses in persons who become HIV controllers', Journal of Virology, 84, pp. 7581 - 7591

Koelsch KK; Xu Y; Bailey M; McBride K; Seddiki N; Suzuki K; Murray J; Cooper DA; Kelleher AD; Zaunders J, 2010, 'Most HIV DNA in PBMC is present in non‐gut homing, resting memory CD4+ T cells with a ß7‐CD38‐CD127 high phenotype', Journal of the International AIDS Society, 13, http://dx.doi.org/10.1186/1758-2652-13-s3-o2

Tong WW; McAllister J; White PA; Kelleher A; Carr A, 2010, 'Transmission of triple-class, drug resistant HIV-1 in Australia', Internal Medicine Journal, 40, pp. 657 - 661, http://dx.doi.org/10.1111/j.1445-5994.2010.02296.x

Venturi V; Chin HY; Asher TE; Ladell K; Scheinberg P; Bornstein E; Van Bockel D; Kelleher AD; Douek DC; Price DA; Davenport MP, 2009, 'TCR β-chain sharing in human CD8⁺ T cell responses to cytomegalovirus and EBV', Journal of Immunology, 181, pp. 7853 - 7862, http://dx.doi.org/10.4049/jimmunol.181.11.7853

Reddy SMR; Center RJ; Suzuki K; Gorry P; Kelleher A; Purcell DF, 2009, 'P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens', Retrovirology, 6, http://dx.doi.org/10.1186/1742-4690-6-S3-P167

Reddy SMR; Center RJ; Suzuki K; Gorry P; Kelleher A; Purcell DF, 2009, 'Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens', RETROVIROLOGY, 6, http://dx.doi.org/10.1186/1742-4690-6-S3-P167

Swaminathan S; Zaunders J; Wilkinson J; Suzuki K; Kelleher AD, 2009, 'Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection?', Blood, 113, pp. 5029 - 5030, http://dx.doi.org/10.1182/blood-2009-01-196741

Munier CM; Zaunders J; Ip S; Cooper DA; Kelleher AD, 2009, 'A culture amplified multi-parametric intracellular cytokine assay (CAMP-ICC) for enhanced detection of antigen specific T-cell responses', Journal of Immunological Methods, 345, pp. 1 - 16

Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576

Zaunders J; Munier ML; Seddiki N; Pett SL; Ip S; Bailey M; Xu Y; Brown KJ; Dyer W; Kim MS; De Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD, 2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)', Journal of Immunology, 183, pp. 2827 - 2836, http://dx.doi.org/10.4049/jimmunol.0803548

Matthews PM; Leslie A; Katzourakis A; Crawford H; Payne R; Prendergast A; Power KA; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung''u T; Walker BD; Allen TM; Pybus O; Goulder PJ, 2009, 'HLA Footprints on human immunodeficiency virus tp 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering', Journal of Virology, 83, pp. 4605 - 4615, http://dx.doi.org/10.1128/JVI.02017-08

Matthews PM; Leslie A; Katzourakis A; Crawford H; Payne R; Prendergast A; Power KA; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung''u T; Walker BD; Allen TM; Pybus O; Goulder PJ, 2009, 'HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering', Journal of Virology, 83, pp. 4605 - 4615, http://jvi.asm.org/content/85/9/4635

Streeck H; Jolin J; Qi YC; Yassine-Diab B; Johnson ; Kwon D; Addo M; Brumme C; Routy J; Little S; Jessen H; Kelleher AD; Hecht FM; Sekaly R; Rosenberg E; Walker BD; Carrington M; Altfeld M, 2009, 'Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells', Journal of Virology, 83, pp. 7641 - 7648

Seddiki N; Sasson SC; Santner-Nanan B; Munier M; Van Bockel DJ; Ip S; Marriott D; Pett SL; Nanan R; Cooper DA; Zaunders J; Kelleher AD, 2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease', European Journal of Immunology, 39, pp. 391 - 403, http://dx.doi.org/10.1002/eji.200838630

Yamagishi M; Ishida T; Miyake A; Cooper DA; Kelleher AD; Suzuki K; Watanabe T, 2009, 'Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription', Microbes and Infection, 11, pp. 500 - 508

Suzuki K; Kelleher AD, 2009, 'Transcriptional regulation by promoter targeted RNAs', Current Topics in Medicinal Chemistry, 9, pp. 1079 - 1087

Back to profile page